Schedule 13G ownership disclosure
Radiopharm Theranostics Ltd
Ordinary Shares, as represented by American Depositary Shares · CUSIP: Q79455103
Event date: 2024-12-31
- Filing-level shares
- 230,880,943
- Percent of class
- 10.2%
- JPMORGAN CHASE & CO.
Shares: 230,880,943 · Class: 10.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000199
- Form type
- SCHEDULE 13G
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Feb 11, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership